Britannia Life Sciences Inc

1M6MYTD1Y5YMAX

Loading quotes...

Chart analytics

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2022, Britannia Life Sciences Inc has already paid 0,0296€ in dividends. The last payout was in July 2022.

Financials

In the last quarter, Britannia Life Sciences Inc had revenue of −175,93k€ and net profit of 2,25M€

(EUR)	Mar 2026	YoY
Revenue	−175,93k	94,62%
Gross profit	−275,46k	87,73%
Net profit	+2,25M	62,94%
EBITDA	−178,31k	92,80%

Fundamentals

Metric	Value
Market capitalization	+7,04M€
Number of shares	162,25M
52-week high/low	+0,0867€ - +0,0372€
Dividends	No
Beta	-0,06
P/E ratio	+0,87
PEG ratio	+0,01
P/B ratio	+0,55
P/S ratio	+23,92

Company profile

Britannia Life Sciences Inc. bietet Produkttests, Sicherheitsbewertungen und Compliance-Dienstleistungen für die Kosmetik-, Nutrazeutika- und Konsumgüterindustrie im Vereinigten Königreich und international an. Das Unternehmen hat seinen Sitz in Toronto, Kanada.